Position in ANVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$634
-$12,150 QoQ
Shares Held
341
-94.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 61 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 41%
Shared 0%
None 59%
Common Shares in ANVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. ANVS ranks #476 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in ANVS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $634 | 341 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $12,784 | 5,733 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $34,257 | 9,901 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $15,295 | 7,389 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $26,460 | 12,194 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $15,283 | 10,189 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $6,539 | 1,300 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $10,881 | 1,350 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $31,668 | 5,498 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $85,154 | 7,156 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $26,815 | 1,434 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $13,607 | 1,434 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $20,176 | 1,412 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $26,211 | 1,701 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $398,280 | 29,656 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $565,631 | 41,287 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $636,604 | 56,138 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $1,469,274 | 110,058 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $2,724,564 | 154,981 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,205,420 | 37,966 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,573,390 | 30,070 | Shares | Defined | 2021-08-23 | |
| 2020-12-31 | $107,716 | 14,286 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $68,715 | 14,286 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||